Prosecution Insights
Last updated: October 25, 2026

Foundation Law Group

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

10 pending office actions • 4 clients • 4 examiners • 4 art units • 0 of 10 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Foundation Law Group has 10 pending office actions in Biotechnology & Pharmaceuticals and 255 career applications. Its resolved allowance rate is 80.11%, and allowed matters average 4.47 office actions. The record shows a current workload and a prosecution history in which allowance is associated with several examination exchanges.

The allowance rate measures outcomes across the career application record, while the action average indicates prosecution effort for matters that reached allowance. That distinction is useful when planning responses and evaluating the practical demands of biotechnology and pharmaceutical prosecution. The application history provides context for the outcome measure, but the figures do not predict the disposition of any individual pending matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=255 apps, methodology: how we score firms)

80.1%
Allowance Rate
n=255
+0.37σ
Allowance Rate (norm)
n=255
4.5
OAs to Allowance
n=149
+0.39σ
OAs to Allow (norm)
n=149
943 days
Time to Allowance
n=149
+4.4pp
Interview Lift
n=255
39.2%
RCE Rate
n=255
0.0%
Appeal Rate
n=255

Rejection Performance (% of received rejections ultimately overcome)

56.2%
§101 Overcome
n=48
63.6%
§102 Overcome
n=77
63.6%
§103 Overcome
n=118
70.9%
§112 Overcome
n=117

Specialization & Scale

G06Q, A61K, G06F
Top CPC Subclasses
20%
Top-3 CPC Share
n=255
1
Practitioners
n=255
255.0
Apps / Practitioner
n=255

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (70%)
2
Medium (20%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (10%)
§101 + other3 (30%)
§112 only1 (10%)
Double-patenting + other2 (20%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
10% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOWELL, THEODORE R 7 66.9% +25.1%
BOWERS, NATHAN ANDREW 1 59.5% +31.7%
CLARY, KAYLA ELAINE 1 66.0% +26.1%
ABOUZAHRA, REHAM K 1 10.5% +8.6%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17745763 COMPOSITE SOLID ELECTROLYTE CLARY, KAYLA ELAINE 91d overdue
18530198 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R 57d
19082306 ELECTRONIC INHALATION DEVICE HOWELL, THEODORE R —
18671814 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —
18530143 TERPENE-BASED COMPOSITIONS, METHODOLGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —
18490846 ACTUATOR HOLDER APPARATUS BOWERS, NATHAN ANDREW —
17336101 RIDE ASSIGNMENT SYSTEM ABOUZAHRA, REHAM K —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17745763 COMPOSITE SOLID ELECTROLYTE CLARY, KAYLA ELAINE 91d overdue
18530198 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R 57d
19188202 ELECTRONIC INHALATION DEVICE HOWELL, THEODORE R —
19082306 ELECTRONIC INHALATION DEVICE HOWELL, THEODORE R —
18671916 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —
18671814 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —
18671969 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —
18530143 TERPENE-BASED COMPOSITIONS, METHODOLGIES FOR CREATION AND PRODUCTS THEREBY HOWELL, THEODORE R —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
16287
17991
17211
36251

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19188202 ELECTRONIC INHALATION DEVICE Scientific Holdings, LLC HOWELL, THEODORE R 1628 §112 Final Rejection — Pending Apr 24, 2025
19082306 ELECTRONIC INHALATION DEVICE Scientific Holdings, LLC HOWELL, THEODORE R 1628 §103§112Other Final Rejection — Pending Mar 18, 2025
18671916 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY Scientific Holdings, LLC HOWELL, THEODORE R 1628 §112DP Non-Final OA — Pending May 22, 2024
18671814 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY Scientific Holdings, LLC HOWELL, THEODORE R 1628 §101§102§112DP Non-Final OA — Pending May 22, 2024
18671969 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY Scientific Holdings, LLC HOWELL, THEODORE R 1628 §112DP Non-Final OA — Pending May 22, 2024
18530198 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY Scientific Holdings, LLC HOWELL, THEODORE R 1628 §101§102§112 Non-Final OA 57d Pending Dec 05, 2023
18530143 TERPENE-BASED COMPOSITIONS, METHODOLGIES FOR CREATION AND PRODUCTS THEREBY Scientific Holdings, LLC HOWELL, THEODORE R 1628 §101§102§103§112 Non-Final OA — Pending Dec 05, 2023
18490846 ACTUATOR HOLDER APPARATUS Chiron On-Chip Biotechnologies B.V. BOWERS, NATHAN ANDREW 1799 §102§103§112 Non-Final OA — Pending Oct 20, 2023
17745763 COMPOSITE SOLID ELECTROLYTE Natrion Inc. CLARY, KAYLA ELAINE 1721 §103§112 Non-Final OA 91d overdue Pending May 16, 2022
17336101 RIDE ASSIGNMENT SYSTEM Hopskipdrive, Inc. ABOUZAHRA, REHAM K 3625 §101 Final Rejection — Pending Jun 01, 2021

Managing Foundation Law Group's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Foundation Law Group's patent allowance rate?

80.1% of resolved applications prosecuted by Foundation Law Group were allowed, across 255 applications in USPTO records.

How many office actions does Foundation Law Group average before allowance?

4.47 office actions per allowed application on average.

How many pending office actions does Foundation Law Group have?

10 pending office actions as of October 2026, for 4 clients, before 4 examiners in 4 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month